Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Levetiracetam/oxcarbazepine/topiramate

Treatment ineffective: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yang H, et al. ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration. Molecular Genetics and Genomic Medicine 10: No. 7, Jul 2022. Available from: URL: http://doi.org/10.1002/mgg3.1967 Yang H, et al. ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration. Molecular Genetics and Genomic Medicine 10: No. 7, Jul 2022. Available from: URL: http://​doi.​org/​10.​1002/​mgg3.​1967
Metadaten
Titel
Levetiracetam/oxcarbazepine/topiramate
Treatment ineffective: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30932-5

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Tozinameran

Case report

Ivosidenib

Case report

Tozinameran